Transcriptomic analysis in the developing zebrafish embryo after compound exposure: Individual gene expression and pathway regulation

Toxicology and Applied Pharmacology

Volumn 272, Issue 1, 2013, Pages 161-171

  Hermsen, Sanne A B ^a,b,c   Pronk, Tessa E ^a,b   van den Brandhof, Evert Jan ^a   van der Ven, Leo T M ^a   Piersma, Aldert H ^a,c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Alternative; Developmental toxicity; Gene expression; Pathway analysis; Transcriptomics; Zebrafish embryo

Indexed keywords

BIOLOGICAL MARKER; CARBAMAZEPINE; MANNITOL; RETINOIC ACID; SACCHARIN; VALPROIC ACID;

ARTICLE; DEVELOPMENTAL TOXICITY; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; ENVIRONMENTAL EXPOSURE; GENE CONTROL; GENE EXPRESSION; HYBRIDIZATION; MORPHOLOGY; NONHUMAN; RNA ISOLATION; RNA PROCESSING; TRANSCRIPTOMICS; ZEBRA FISH;

ALTERNATIVE; DEVELOPMENTAL TOXICITY; GENE EXPRESSION; PATHWAY ANALYSIS; TRANSCRIPTOMICS; ZEBRAFISH EMBRYO;

ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; CAFFEINE; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM STIMULANTS; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICROARRAY ANALYSIS; RNA; SIGNAL TRANSDUCTION; TERATOGENS; TRANSCRIPTOME;

EID: 84882779752     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.05.037     Document Type: Article

References (80)

1. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 1995, 57:289-300.
2. Bosetti F., Bell J.M., Manickam P. Microarray analysis of rat brain gene expression after chronic administration of sodium valproate. Brain Res. Bull. 2005, 65:331-338.
3. Brannen K.C., Panzica-Kelly J.M., Danberry T.L., Augustine-Rauch K.A. Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. Birth Defects Res. B Dev. Reprod. Toxicol. 2010, 89:66-77.
4. Bronner M.E., LeDouarin N.M. Development and evolution of the neural crest: an overview. Dev. Biol. 2012, 366:2-9.
5. Capiotti K.M., Menezes F.P., Nazario L.R., Pohlmann J.B., de Oliveira G.M., Fazenda L., Bogo M.R., Bonan C.D., Da Silva R.S. Early exposure to caffeine affects gene expression of adenosine receptors, DARPP-32 and BDNF without affecting sensibility and morphology of developing zebrafish (Danio rerio). Neurotoxicol. Teratol. 2011, 33:680-685.
6. Chateauvieux S., Morceau F., Dicato M., Diederich M. Molecular and therapeutic potential and toxicity of valproic acid. J. Biomed. Biotechnol. 2010, 2010.
7. Chen L., Bell E.M., Browne M.L., Druschel C.M., Romitti P.A., Schmidt R.J., Burns T.L., Moslehi R., Olney R.S. Maternal caffeine consumption and risk of congenital limb deficiencies. Birth Defects Res. A Clin. Mol. Teratol. 2012, 94:1033-1043.
8. Connolly S., Kingsbury T.J. Caffeine modulates CREB-dependent gene expression in developing cortical neurons. Biochem. Biophys. Res. Commun. 2010, 397:152-156.
9. Cui X., Churchill G.A. Statistical tests for differential expression in cDNA microarray experiments. Genome Biol. 2003, 4:210.
10. Cvekl A., Wang W.L. Retinoic acid signaling in mammalian eye development. Exp. Eye Res. 2009, 89:280-291.
11. Duncan S. Teratogenesis of sodium valproate. Curr. Opin. Neurol. 2007, 20:175-180.
12. Eisen J.S., Weston J.A. Development of the neural crest in the zebrafish. Dev. Biol. 1993, 159:50-59.
13. EU Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Off. J. Eur. Union 2010, L276:33-79.
14. Fuller L.C., Cornelius S.K., Murphy C.W., Wiens D.J. Neural crest cell motility in valproic acid. Reprod. Toxicol. 2002, 16:825-839.
15. Gammill L.S., Bronner-Fraser M. Neural crest specification: migrating into genomics. Nat. Rev. Neurosci. 2003, 4:795-805.
16. Gaytan S.P., Pasaro R. Neonatal caffeine treatment up-regulates adenosine receptors in brainstem and hypothalamic cardio-respiratory related nuclei of rat pups. Exp. Neurol. 2012, 237:247-259.
17. Hermsen S.A.B., Pronk T.E., van den Brandhof E.J., van der Ven L.T.M., Piersma A.H. Chemical class-specific gene expression changes in the zebrafish embryo after exposure to glycol ether alkoxy acids and 1,2,4-triazole antifungals. Reprod. Toxicol. 2011, 32:245-252.
18. Hermsen S.A.B., van den Brandhof E.-J., van der Ven L.T.M., Piersma A.H. Relative embryotoxicity of two classes of chemicals in a modified zebrafish embryotoxicity test and comparison with their in vivo potencies. Toxicol. In Vitro 2011, 25:745-753.
19. Hermsen S.A.B., Pronk T.E., van den Brandhof E.J., van der Ven L.T., Piersma A.H. Triazole-induced gene expression changes in the zebrafish embryo. Reprod. Toxicol. 2012, 34:216-224.
20. Hermsen S.A.B., Pronk T.E., van den Brandhof E.J., van der Ven L.T.M., Piersma A.H. Concentration-response analysis of differential gene expression in the zebrafish embryotoxicity test following flusilazole exposure. Toxicol. Sci. 2012, 127:303-312.
21. Herrmann K. Effects of the anticonvulsant drug valproic acid and related substances on the early development of the zebrafish (Brachydanio rerio). Toxicol. In Vitro 1993, 7:41-54.
22. Jentink J., Dolk H., Loane M.A., Morris J.K., Wellesley D., Garne E., de Jong-van den Berg L. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ 2010, 341:c6581.
23. Jentink J., Loane M.A., Dolk H., Barisic I., Garne E., Morris J.K., de Jong-van den Berg L.T. Valproic acid monotherapy in pregnancy and major congenital malformations. N. Engl. J. Med. 2010, 362:2185-2193.
24. Kerr M.K., Martin M., Churchill G.A. Analysis of variance for gene expression microarray data. J. Comput. Biol. 2000, 7:819-837.
25. Kim W.J., Lee J.H., Yi J., Cho Y.J., Heo K., Lee S.H., Kim S.W., Kim M.K., Kim K.H., In Lee B., Lee M.G. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet. Genomics 2010, 20:249-256.
26. Kimmel C.B., Ballard W.W., Kimmel S.R., Ullmann B., Schilling T.F. Stages of embryonic development of the zebrafish. Dev. Dyn. 1995, 203:253-310.
27. Kostrouchova M., Kostrouch Z., Kostrouchova M. Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biol. (Praha) 2007, 53:37-49.
28. Krewski D., Acosta D., Andersen M., Anderson H., Bailar J.C., Boekelheide K., Brent R., Charnley G., Cheung V.G., Green S., Kelsey K.T., Kerkvliet N.I., Li A.A., McCray L., Meyer O., Patterson R.D., Pennie W., Scala R.A., Solomon G.M., Stephens M., Yager J., Zeise L. Toxicity testing in the 21st century: a vision and a strategy. J. Toxicol. Environ. Health B Crit. Rev. 2010, 13:51-138.
29. Lempiainen H., Shore D. Growth control and ribosome biogenesis. Curr. Opin. Cell Biol. 2009, 21:855-863.
30. Lucitt M.B., Price T.S., Pizarro A., Wu W., Yocum A.K., Seiler C., Pack M.A., Blair I.A., Fitzgerald G.A., Grosser T. Analysis of the zebrafish proteome during embryonic development. Mol. Cell. Proteomics 2008, 7:981-994.
31. Ma Z.L., Qin Y., Wang G., Li X.D., He R.R., Chuai M., Kurihara H., Yang X. Exploring the caffeine-induced teratogenicity on neurodevelopment using early chick embryo. PLoS One 2012, 7:e34278.
32. Maden M., Gale E., Zile M. The role of vitamin A in the development of the central nervous system. J. Nutr. 1998, 128:471S-475S.
33. Martin M.T., Brennan R.J., Hu W., Ayanoglu E., Lau C., Ren H., Wood C.R., Corton J.C., Kavlock R.J., Dix D.J. Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity. Toxicol. Sci. 2007, 97:595-613.
34. Martinez-Morales P.L., Diez del Corral R., Olivera-Martinez I., Quiroga A.C., Das R.M., Barbas J.A., Storey K.G., Morales A.V. FGF and retinoic acid activity gradients control the timing of neural crest cell emigration in the trunk. J. Cell Biol. 2011, 194:489-503.
35. Matalon S., Schechtman S., Goldzweig G., Ornoy A. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod. Toxicol. 2002, 16:9-17.
36. McCollum C.W., Ducharme N.A., Bondesson M., Gustafsson J.A. Developmental toxicity screening in zebrafish. Birth Defects Res. C Embryo Today 2011, 93:67-114.
37. Menegola E., Broccia M.L., Di Renzo F., Massa V., Giavini E. Relationship between hindbrain segmentation, neural crest cell migration and branchial arch abnormalities in rat embryos exposed to fluconazole and retinoic acid in vitro. Reprod. Toxicol. 2004, 18:121-130.
38. Meulemans D., Bronner-Fraser M. Gene-regulatory interactions in neural crest evolution and development. Dev. Cell 2004, 7:291-299.
39. Nagel R. DarT: the embryo test with the zebrafish Danio rerio-a general model in ecotoxicology and toxicology. ALTEX 2002, 19(Suppl. 1):38-48.
40. Nakabayashi H., Hashimoto T., Ashida H., Nishiumi S., Kanazawa K. Inhibitory effects of caffeine and its metabolites on intracellular lipid accumulation in murine 3T3-L1 adipocytes. Biofactors 2008, 34:293-302.
41. Okada A., Fujiwara M. Molecular approaches to developmental malformations using analogous forms of valproic acid. Congenit. Anom. (Kyoto) 2006, 46:68-75.
42. Okada A., Kushima K., Aoki Y., Bialer M., Fujiwara M. Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice. Birth Defects Res. A Clin. Mol. Teratol. 2005, 73:229-238.
43. Oscarson M., Zanger U.M., Rifki O.F., Klein K., Eichelbaum M., Meyer U.A. Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin. Pharmacol. Ther. 2006, 80:440-456.
44. Pearson K. On lines and planes of closest fit to systems of points in space. Philos. Mag. 1901, 2:559-572.
45. Pennati R., Groppelli S., de Bernardi F., Sotgia C. Action of valproic acid on Xenopus laevis development: teratogenic effects on eyes. Teratog. Carcinog. Mutagen. 2001, 21:121-133.
46. Pennings J.L., van Dartel D.A., Robinson J.F., Pronk T.E., Piersma A.H. Gene set assembly for quantitative prediction of developmental toxicity in the embryonic stem cell test. Toxicology 2011, 284:63-71.
47. Pennings J.L., Theunissen P.T., Piersma A.H. An optimized gene set for transcriptomics based neurodevelopmental toxicity prediction in the neural embryonic stem cell test. Toxicology 2012, 300:158-167.
48. Piersma A.H., Verhoef A., Opperhuizen A., Klaassen R., van Eijkeren J., Olling M. Embryotoxicity of carbamazepine in rat postimplantation embryo culture after in vitro exposure via three different routes. Reprod. Toxicol. 1998, 12:161-168.
49. Piersma A.H., Janer G., Wolterink G., Bessems J.G.M., Hakkert B.C., Slob W. Quantitative extrapolation of in vitro whole embryo culture embryotoxicity data to developmental toxicity in vivo using the benchmark dose approach. Toxicol. Sci. 2008, 101:91-100.
50. Plant N., Barber P., Horner E., Cockburn C.L., Gibson G., Bugelski P., Lord P. Differential gene expression in rats following subacute exposure to the anticonvulsant sodium valproate. Toxicol. Appl. Pharmacol. 2002, 183:127-134.
51. Robinson J.F., van Beelen V.A., Verhoef A., Renkens M.F.J., Luijten M., van Herwijnen M.H.M., Westerman A., Pennings J.L.A., Piersma A.H. Embryotoxicant-specific transcriptomic responses in rat postimplantation whole-embryo culture. Toxicol. Sci. 2010, 118:675-685.
52. Robinson J.F., Theunissen P.T., van Dartel D.A.M., Pennings J.L., Faustman E.M., Piersma A.H. Comparison of MeHg-induced toxicogenomic responses across in vivo and in vitro models used in developmental toxicology. Reprod. Toxicol. 2011, 32:180-188.
53. Robinson J.F., Verhoef A., Pennings J.L., Pronk T.E., Piersma A.H. A comparison of gene expression responses in rat whole embryo culture and in vivo: time-dependent retinoic acid-induced teratogenic response. Toxicol. Sci. 2012, 126:242-254.
54. Robinson J.F., Verhoef A., van Beelen V.A., Pennings J.L., Piersma A.H. Dose-response analysis of phthalate effects on gene expression in rat whole embryo culture. Toxicol. Appl. Pharmacol. 2012, 264:32-41.
55. Sauka-Spengler T., Meulemans D., Jones M., Bronner-Fraser M. Ancient evolutionary origin of the neural crest gene regulatory network. Dev. Cell 2007, 13:405-420.
56. Selderslaghs I.W., Van Rompay A.R., De Coen W., Witters H.E. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. Reprod. Toxicol. 2009, 28:308-320.
57. Selderslaghs I.W., Blust R., Witters H.E. Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds. Reprod. Toxicol. 2012, 33:142-154.
58. Slob W. Dose-response modeling of continuous endpoints. Toxicol. Sci. 2002, 66:298-312.
59. Steiner G., Suter L., Boess F., Gasser R., de Vera M.C., Albertini S., Ruepp S. Discriminating different classes of toxicants by transcript profiling. Environ. Health Perspect. 2004, 112:1236-1248.
60. Strahle U., Scholz S., Geisler R., Greiner P., Hollert H., Rastegar S., Schumacher A., Selderslaghs I., Weiss C., Witters H., Braunbeck T. Zebrafish embryos as an alternative to animal experiments-a commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod. Toxicol. 2012, 33:128-132.
61. Teixido E., Pique E., Gomez-Catalan J., Llobet J.M. Assessment of developmental delay in the zebrafish embryo teratogenicity assay. Toxicol. In Vitro 2013, 27:469-478.
62. Tembe E.A., Honeywell R., Buss N.E., Renwick A.G. All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits. Toxicol. Appl. Pharmacol. 1996, 141:456-472.
63. Theunissen P.T., Robinson J.F., Pennings J.L., de Jong E., Claessen S.M., Kleinjans J.C., Piersma A.H. Transcriptomic concentration-response evaluation of valproic acid, cyproconazole, and hexaconazole in the neural embryonic stem cell test (ESTn). Toxicol. Sci. 2012, 125:430-438.
64. Theunissen P.T., Robinson J.F., Pennings J.L., van Herwijnen M.H., Kleinjans J.C., Piersma A.H. Compound-specific effects of diverse neurodevelopmental toxicants on global gene expression in the neural embryonic stem cell test (ESTn). Toxicol. Appl. Pharmacol. 2012, 262:330-340.
65. Thisse B., Thisse C. Fast release clones: a high throughput expression analysis. ZFIN Direct Data Submission 2004, (http://zfin.org).
66. Turton J.A., Willars G.B., Haselden J.N., Ward S.J., Steele C.E., Hicks R.M. Comparative teratogenicity of nine retinoids in the rat. Int. J. Exp. Pathol. 1992, 73:551-563.
67. Uechi T., Nakajima Y., Nakao A., Torihara H., Chakraborty A., Inoue K., Kenmochi N. Ribosomal protein gene knockdown causes developmental defects in zebrafish. PLoS One 2006, 1:e37.
68. Uehara T., Hirode M., Ono A., Kiyosawa N., Omura K., Shimizu T., Mizukawa Y., Miyagishima T., Nagao T., Urushidani T. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. Toxicology 2008, 250:15-26.
69. van Dartel D.A., Pennings J.L., Hendriksen P.J., van Schooten F.J., Piersma A.H. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate. Reprod. Toxicol. 2009, 27:93-102.
70. van Dartel D.A., Pennings J.L., de la Fonteyne L.J., van Herwijnen M.H., van Delft J.H., van Schooten F.J., Piersma A.H. Monitoring developmental toxicity in the embryonic stem cell test using differential gene expression of differentiation-related genes. Toxicol. Sci. 2010, 116:130-139.
71. van Dartel D.A.M., Pennings J.L.A., de la Fonteyne L.J.J., Brauers K.J.J., Claessen S., van Delft J.H., Kleinjans J.C.S., Piersma A.H. Concentration-dependent gene expression responses to flusilazole in embryonic stem cell differentiation cultures. Toxicol. Appl. Pharmacol. 2011, 251:110-118.
72. van Dartel D.A.M., Pennings J.L.A., Robinson J.F., Kleinjans J.C.S., Piersma A.H. Discriminating classes of developmental toxicants using gene expression profiling in the embryonic stem cell test. Toxicol. Lett. 2011, 201:143-151.
73. Van den Bulck K., Hill A., Mesens N., Diekman H., De Schaepdrijver L., Lammens L. Zebrafish developmental toxicity assay: a fishy solution to reproductive toxicity screening, or just a red herring?. Reprod. Toxicol. 2011, 32:213-219.
74. Vieux-Rochas M., Bouhali K., Baudry S., Fontaine A., Coen L., Levi G. Irreversible effects of retinoic acid pulse on Xenopus jaw morphogenesis: new insight into cranial neural crest specification. Birth Defects Res. B Dev. Reprod. Toxicol. 2010, 89:493-503.
75. Wang H., Kesinger J.W., Zhou Q., Wren J.D., Martin G., Turner S., Tang Y., Frank M.B., Centola M. Identification and characterization of zebrafish ocular formation genes. Genome 2008, 51:222-235.
76. Wolfinger R.D., Gibson G., Wolfinger E.D., Bennett L., Hamadeh H., Bushel P., Afshari C., Paules R.S. Assessing gene significance from cDNA microarray expression data via mixed models. J. Comput. Biol. 2001, 8:625-637.
77. Wu H., Kerr M.K., Cui X., Churchill G.A. MAANOVA: a software package for the analysis of spotted cDNA microarray experiments. The Analysis of Gene Expression Data 2003, 313-341. Springer, London. G. Parmigiani, E. Garrett, R. Irizarry, S. Zeger (Eds.).
78. Yang L., Allen B., Thomas R. BMDExpress: a software tool for the benchmark dose analyses of genomic data. BMC Genomics 2007, 8:387.
79. Yang L., Kemadjou J.R., Zinsmeister C., Bauer M., Legradi J., Muller F., Pankratz M., Jakel J., Strahle U. Transcriptional profiling reveals barcode-like toxicogenomic responses in the zebrafish embryo. Genome Biol. 2007, 8:R227.
80. Zhao Y., Ju F., Wang L., Sun Z., Liu M., Gao L. The expression of alphaA- and betaB1-crystallin during normal development and regeneration, and proteomic analysis for the regenerating lens in Xenopus laevis. Mol. Vis. 2011, 17:768-778.